SMTL ID : 6pm9.2 (1 other biounit)

Crystal structure of the core catalytic domain of human O-GlcNAcase bound to MK-8719

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.86 Å

Oligo State

hetero-2-2-mer

Ligands

2 x OQ1: (3aR,5S,6S,7R,7aR)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d][1,3]thiazole-6,7-diol(Non-covalent)

OQ1.1: 17 residues within 4Å: Chain A: G.55, F.56, Y.57, K.86, D.162, C.203, Y.207, T.238, V.242, V.243, W.266, N.268, A.271, D.273, Y.274, N.301 Chain C: W.127 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:T.238, A:W.266 Hydrogen bonds: A:G.55, A:G.55, A:K.86, A:D.162, A:N.301 OQ1.2: 17 residues within 4Å: Chain B: G.55, F.56, Y.57, K.86, D.162, C.203, Y.207, T.238, V.242, V.243, W.266, N.268, A.271, D.273, Y.274, N.301 Chain D: W.127 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:T.238, B:W.266 Hydrogen bonds: B:G.55, B:G.55, B:K.86, B:D.162, B:N.301

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Selnick, H.G. et al., Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies. J.Med.Chem. (2019)

Release Date

2019-09-18

Peptides

O-GlcNAcase TIM-barrel domain: AB
O-GlcNAcase stalk domain: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
E

D
H

O-GlcNAcase TIM-barrel domain

O-GlcNAcase stalk domain

Related Entries With Identical Sequence